Sito in Italia dove è possibile acquistare la consegna acquisto Viagra a buon mercato e di alta qualità in ogni parte del mondo.

Untitled

Howard Solomon, Chief Executive OfficerForest Pharmaceuticals160 East 72nd St,New York, NY 10021-4364 I write to inquire about your business relationship with Huntingdon Life Sciences (HLS), a contract laboratory Forest Pharmaceuticals employs to conduct toxicity tests on animals.
Are you aware that HLS has accumulated 32 affirmed violations of the U.S. Animal Welfare Act, 16 violations of Good Laboratory Practice in England, and the arrest of employees on animal cruelty charges? Your firm stands to lose worldwide credibility if it refuses to recognize the illegal animal abuse and sloppy science revealed in numerous HLS investigations.
I strongly encourage Forest Pharmaceuticals to join Procter & Gamble, Rhom and Haas, Allergan, Merck, CBC Co. Ltd. and other companies that opted to forgo the hassle of Huntingdon’s plummeting stock price, near bankruptcy and tendency to attract complaints and protests. Please make the responsible decision to cut ties with HLS. Certainly a firm of your stature has the integrity to work with businesses that enhance our world. HLS is not among those businesses.
In a $50,000 settlement with the U.S. Department of Agriculture, HLS was charged with over 20 counts of violating anti-cruelty laws, including: Failure to provide sufficient veterinary care; failure to administer painkillers and anesthetics to animals used in excruciating toxicology tests; failure to justify the absence of pain relief for dogs utilized in invasive procedures; and failure to construct cages that safeguard animals from injury.
A one-time HLS employee claims she regularly heard the yelping and coughing of conscious dogs during fatal procedures. Other former employees and undercover videos expose workers slamming monkeys into cages, punching beagle puppies in the face and dangling animals in mid-air while pumping test materials into their stomachs. More videotaped evidence shows HLS workers slicing into the flesh of live animals during presumably post-mortem dissection.
Great strides have been made to replace animal experiments with sophisticated non-animal modalities that generate data applicable to human health and safety. I urge Forest to evolve with the most proficient and humane technologies available when authorizing tests for such drugs as Celexa—your company’s panacea to the uniquely American “Compulsive Shopping Disorder” (CSD). Please don’t let the truth behind Celexa be the torture of animals inside HLS.
I hope Forest Pharmaceuticals will phase out non-predictive animals tests in favor of validated non-animal research tools. At the very least, please do not place orders with HLS, a facility that has falsified research records and violated animal welfare laws over 600 times.
Greg Yurchak, Cincinnati plant managerForest Pharmaceuticals6238 Chappellfield DriveWest Chester, OH 45069ph & fax: 513-759-9207; email: gregory.yurchak@fuse.net I write to inquire about your business relationship with Huntingdon Life Sciences (HLS), a contract laboratory Forest Pharmaceuticals employs to conduct toxicity tests on animals.
Are you aware that HLS has accumulated 32 affirmed violations of the U.S. Animal Welfare Act, 16 violations of Good Laboratory Practice in England, and the arrest of employees on animal cruelty charges? Your firm stands to lose worldwide credibility if it refuses to recognize the illegal animal abuse and sloppy science revealed in numerous HLS investigations.
I strongly encourage Forest Pharmaceuticals to join Procter & Gamble, Rhom and Haas, Allergan, Merck, CBC Co. Ltd. and other companies that opted to forgo the hassle of Huntingdon’s plummeting stock price, near bankruptcy and tendency to attract complaints and protests. Please make the responsible decision to cut ties with HLS. Certainly a firm of your stature has the integrity to work with businesses that enhance our world. HLS is not among those businesses.
In a $50,000 settlement with the U.S. Department of Agriculture, HLS was charged with over 20 counts of violating anti-cruelty laws, including: Failure to provide sufficient veterinary care; failure to administer painkillers and anesthetics to animals used in excruciating toxicology tests; failure to justify the absence of pain relief for dogs utilized in invasive procedures; and failure to construct cages that safeguard animals from injury.
A one-time HLS employee claims she regularly heard the yelping and coughing of conscious dogs during fatal procedures. Other former employees and undercover videos expose workers slamming monkeys into cages, punching beagle puppies in the face and dangling animals in mid-air while pumping test materials into their stomachs. More videotaped evidence shows HLS workers slicing into the flesh of live animals during presumably post-mortem dissection.
Great strides have been made to replace animal experiments with sophisticated non-animal modalities that generate data applicable to human health and safety. I urge Forest to evolve with the most proficient and humane technologies available when authorizing tests for such drugs as Celexa—your company’s panacea to the uniquely American “Compulsive Shopping Disorder” (CSD). Please don’t let the truth behind Celexa be the torture of animals inside HLS.
I hope Forest Pharmaceuticals will phase out non-predictive animals tests in favor of validated non-animal research tools. At the very least, please do not place orders with HLS, a facility that has falsified research records and violated animal welfare laws over 600 times.
Leroy Salans, DirectorForest Pharmaceuticals21 East 90th St,New York, NY 10128-0654 ph: 212-831-9360 I write to inquire about your business relationship with Huntingdon Life Sciences (HLS), a contract laboratory Forest Pharmaceuticals employs to conduct toxicity tests on animals.
Are you aware that HLS has accumulated 32 affirmed violations of the U.S. Animal Welfare Act, 16 violations of Good Laboratory Practice in England, and the arrest of employees on animal cruelty charges? Your firm stands to lose worldwide credibility if it refuses to recognize the illegal animal abuse and sloppy science revealed in numerous HLS investigations.
I strongly encourage Forest Pharmaceuticals to join Procter & Gamble, Rhom and Haas, Allergan, Merck, CBC Co. Ltd. and other companies that opted to forgo the hassle of Huntingdon’s plummeting stock price, near bankruptcy and tendency to attract complaints and protests. Please make the responsible decision to cut ties with HLS. Certainly a firm of your stature has the integrity to work with businesses that enhance our world. HLS is not among those businesses.
In a $50,000 settlement with the U.S. Department of Agriculture, HLS was charged with over 20 counts of violating anti-cruelty laws, including: Failure to provide sufficient veterinary care; failure to administer painkillers and anesthetics to animals used in excruciating toxicology tests; failure to justify the absence of pain relief for dogs utilized in invasive procedures; and failure to construct cages that safeguard animals from injury.
A one-time HLS employee claims she regularly heard the yelping and coughing of conscious dogs during fatal procedures. Other former employees and undercover videos expose workers slamming monkeys into cages, punching beagle puppies in the face and dangling animals in mid-air while pumping test materials into their stomachs. More videotaped evidence shows HLS workers slicing into the flesh of live animals during presumably post-mortem dissection.
Great strides have been made to replace animal experiments with sophisticated non-animal modalities that generate data applicable to human health and safety. I urge Forest to evolve with the most proficient and humane technologies available when authorizing tests for such drugs as Celexa—your company’s panacea to the uniquely American “Compulsive Shopping Disorder” (CSD). Please don’t let the truth behind Celexa be the torture of animals inside HLS.
I hope Forest Pharmaceuticals will phase out non-predictive animals tests in favor of validated non-animal research tools. At the very least, please do not place orders with HLS, a facility that has falsified research records and violated animal welfare laws over 600 times.
Forest Pharmaceuticals3941 Brotherton Rd.
Cincinnati, OH 45209ph: 513-271-6800, ext: 503; fax: 513-271-6801 I write to inquire about your business relationship with Huntingdon Life Sciences (HLS), a contract laboratory Forest Pharmaceuticals employs to conduct toxicity tests on animals.
Are you aware that HLS has accumulated 32 affirmed violations of the U.S. Animal Welfare Act, 16 violations of Good Laboratory Practice in England, and the arrest of employees on animal cruelty charges? Your firm stands to lose worldwide credibility if it refuses to recognize the illegal animal abuse and sloppy science revealed in numerous HLS investigations.
I strongly encourage Forest Pharmaceuticals to join Procter & Gamble, Rhom and Haas, Allergan, Merck, CBC Co. Ltd. and other companies that opted to forgo the hassle of Huntingdon’s plummeting stock price, near bankruptcy and tendency to attract complaints and protests. Please make the responsible decision to cut ties with HLS. Certainly a firm of your stature has the integrity to work with businesses that enhance our world. HLS is not among those businesses.
In a $50,000 settlement with the U.S. Department of Agriculture, HLS was charged with over 20 counts of violating anti-cruelty laws, including: Failure to provide sufficient veterinary care; failure to administer painkillers and anesthetics to animals used in excruciating toxicology tests; failure to justify the absence of pain relief for dogs utilized in invasive procedures; and failure to construct cages that safeguard animals from injury.
A one-time HLS employee claims she regularly heard the yelping and coughing of conscious dogs during fatal procedures. Other former employees and undercover videos expose workers slamming monkeys into cages, punching beagle puppies in the face and dangling animals in mid-air while pumping test materials into their stomachs. More videotaped evidence shows HLS workers slicing into the flesh of live animals during presumably post-mortem dissection.
Great strides have been made to replace animal experiments with sophisticated non-animal modalities that generate data applicable to human health and safety. I urge Forest to evolve with the most proficient and humane technologies available when authorizing tests for such drugs as Celexa—your company’s panacea to the uniquely American “Compulsive Shopping Disorder” (CSD). Please don’t let the truth behind Celexa be the torture of animals inside HLS.
I hope Forest Pharmaceuticals will phase out non-predictive animals tests in favor of validated non-animal research tools. At the very least, please do not place orders with HLS, a facility that has falsified research records and violated animal welfare laws over 600 times.
Forest Laboratories Inc. Corporate Headquarters909 Third AvenueNew York, NY 10022ph: 212-421-7850; fax: 212-750-9152 I write to inquire about your business relationship with Huntingdon Life Sciences (HLS), a contract laboratory Forest Pharmaceuticals employs to conduct toxicity tests on animals.
Are you aware that HLS has accumulated 32 affirmed violations of the U.S. Animal Welfare Act, 16 violations of Good Laboratory Practice in England, and the arrest of employees on animal cruelty charges? Your firm stands to lose worldwide credibility if it refuses to recognize the illegal animal abuse and sloppy science revealed in numerous HLS investigations.
I strongly encourage Forest Pharmaceuticals to join Procter & Gamble, Rhom and Haas, Allergan, Merck, CBC Co. Ltd. and other companies that opted to forgo the hassle of Huntingdon’s plummeting stock price, near bankruptcy and tendency to attract complaints and protests. Please make the responsible decision to cut ties with HLS. Certainly a firm of your stature has the integrity to work with businesses that enhance our world. HLS is not among those businesses.
In a $50,000 settlement with the U.S. Department of Agriculture, HLS was charged with over 20 counts of violating anti-cruelty laws, including: Failure to provide sufficient veterinary care; failure to administer painkillers and anesthetics to animals used in excruciating toxicology tests; failure to justify the absence of pain relief for dogs utilized in invasive procedures; and failure to construct cages that safeguard animals from injury.
A one-time HLS employee claims she regularly heard the yelping and coughing of conscious dogs during fatal procedures. Other former employees and undercover videos expose workers slamming monkeys into cages, punching beagle puppies in the face and dangling animals in mid-air while pumping test materials into their stomachs. More videotaped evidence shows HLS workers slicing into the flesh of live animals during presumably post-mortem dissection.
Great strides have been made to replace animal experiments with sophisticated non-animal modalities that generate data applicable to human health and safety. I urge Forest to evolve with the most proficient and humane technologies available when authorizing tests for such drugs as Celexa—your company’s panacea to the uniquely American “Compulsive Shopping Disorder” (CSD). Please don’t let the truth behind Celexa be the torture of animals inside HLS.
I hope Forest Pharmaceuticals will phase out non-predictive animals tests in favor of validated non-animal research tools. At the very least, please do not place orders with HLS, a facility that has falsified research records and violated animal welfare laws over 600 times.
Forest PharmaceuticalsSales & Distribution13600 Shoreline DriveSt. Louis, MO 63045toll free: 800-678-1605; ph: 212-224-6676; fax: 314-493-7450 I write to inquire about your business relationship with Huntingdon Life Sciences (HLS), a contract laboratory Forest Pharmaceuticals employs to conduct toxicity tests on animals.
Are you aware that HLS has accumulated 32 affirmed violations of the U.S. Animal Welfare Act, 16 violations of Good Laboratory Practice in England, and the arrest of employees on animal cruelty charges? Your firm stands to lose worldwide credibility if it refuses to recognize the illegal animal abuse and sloppy science revealed in numerous HLS investigations.
I strongly encourage Forest Pharmaceuticals to join Procter & Gamble, Rhom and Haas, Allergan, Merck, CBC Co. Ltd. and other companies that opted to forgo the hassle of Huntingdon’s plummeting stock price, near bankruptcy and tendency to attract complaints and protests. Please make the responsible decision to cut ties with HLS. Certainly a firm of your stature has the integrity to work with businesses that enhance our world. HLS is not among those businesses.
In a $50,000 settlement with the U.S. Department of Agriculture, HLS was charged with over 20 counts of violating anti-cruelty laws, including: Failure to provide sufficient veterinary care; failure to administer painkillers and anesthetics to animals used in excruciating toxicology tests; failure to justify the absence of pain relief for dogs utilized in invasive procedures; and failure to construct cages that safeguard animals from injury.
A one-time HLS employee claims she regularly heard the yelping and coughing of conscious dogs during fatal procedures. Other former employees and undercover videos expose workers slamming monkeys into cages, punching beagle puppies in the face and dangling animals in mid-air while pumping test materials into their stomachs. More videotaped evidence shows HLS workers slicing into the flesh of live animals during presumably post-mortem dissection.
Great strides have been made to replace animal experiments with sophisticated non-animal modalities that generate data applicable to human health and safety. I urge Forest to evolve with the most proficient and humane technologies available when authorizing tests for such drugs as Celexa—your company’s panacea to the uniquely American “Compulsive Shopping Disorder” (CSD). Please don’t let the truth behind Celexa be the torture of animals inside HLS.
I hope Forest Pharmaceuticals will phase out non-predictive animals tests in favor of validated non-animal research tools. At the very least, please do not place orders with HLS, a facility that has falsified research records and violated animal welfare laws over 600 times.
FOREST PHARMACEUTICAL EMAIL BLOCK:
gregory.yurchak@fuse.net, davepilcher@msn.com, rrajasekaran@forestpharm.com,
info@forestpharm.com, dstarek@forestpharm.com, rPrabhala@forestpharm.com,
tbelding@forestpharm.com, Dweber@forestpharm.com, ccurran@forestpharm.com,
dwesche@forestpharm.com, dwentzel@forestpharm.com, weixing.hao@frx.com,
xiaoping.zhang@frx.com, charles.triano@frx.com, katherine.farrington@frx.com,
cecil.hypolite@frx.com, bernard.mcgovern@frx.com, tyler.sherman@frx.com,
michael.pugsley@frx.com, peng.qu@frx.com, timothy.schmitt@frx.com,
kevin.grubb@frx.com, robert.palmer@frx.com, theresa.fico@frx.com,
greg.fontenot@frx.com, david.williams@frx.com, haile.gault@frx.com,
partha.Roy@frx.com, marcelo.gutierrez@frx.com, rajiv.janjikhel@frx.com, prex@imro-
frx.com, rick.calabrese@frx.com, elainehochberg@frx.com, jay.boatman@frx.com,
staffing_nj@frx.com, staffing@frx.com, tim.billiter@frx.com, archley.prudent@frx.com,
tracy.copeland@frx.com, jose.freire-moar@frx.com, hazelflame@imro-frx.com,
joy.rajigah@frx.com, jack.russo@frx.com, janet.Bethea@frx.com
EMAIL BLOCK WITHOUT COMMAS:
gregory.yurchak@fuse.net
davepilcher@msn.com
rrajasekaran@forestpharm.com
info@forestpharm.com
dstarek@forestpharm.com
rPrabhala@forestpharm.com
tbelding@forestpharm.com
Dweber@forestpharm.com
ccurran@forestpharm.com
dwesche@forestpharm.com
dwentzel@forestpharm.com
weixing.hao@frx.com
xiaoping.zhang@frx.com
charles.triano@frx.com
katherine.farrington@frx.com
cecil.hypolite@frx.com
bernard.mcgovern@frx.com
tyler.sherman@frx.com
michael.pugsley@frx.com
peng.qu@frx.com
timothy.schmitt@frx.com
kevin.grubb@frx.com
robert.palmer@frx.com
theresa.fico@frx.com
greg.fontenot@frx.com
david.williams@frx.com
haile.gault@frx.com
partha.Roy@frx.com
marcelo.gutierrez@frx.com
rajiv.janjikhel@frx.comprex@imro-frx.comrick.calabrese@frx.comelainehochberg@frx.comjay.boatman@frx.comstaffing_nj@frx.comstaffing@frx.comtim.billiter@frx.comarchley.prudent@frx.comtracy.copeland@frx.comjose.freire-moar@frx.comhazelflame@imro-frx.comjoy.rajigah@frx.comjack.russo@frx.comjanet.Bethea@frx.com

Source: http://www.kinshipcircle.org/letter_library/pdf/1054.pdf

iter.ac.in

Present Research Activity and Publications (2007-continuing…) Conferences: 1. Sanghamitra Pradhan, National workshop on Nano-materials as Nano-catalyst, January 2 . Sanghamitra Pradhan, 77th National Workshop on Radiochemistry and applications of radioisotopes, 28th November – 6th December 2011, Bhubaneswar, India. 3. Sanghamitra Pradhan , Delivered a talk on Stereochemical a

Dyazide

PRESCRIBING INFORMATION DYAZIDE® (hydrochlorothiazide/triamterene) Capsules DESCRIPTION Each capsule of DYAZIDE (hydrochlorothiazide and triamterene) for oral use, with opaque red cap and opaque white body, contains hydrochlorothiazide 25 mg and triamterene 37.5 mg, and is imprinted with the product name DYAZIDE and SB. Hydrochlorothiazide is a diuretic/antihypertensive agent

Copyright © 2010-2014 Medicament Inoculation Pdf